Boardroom Alpha
S-1/A primary document
PLYX · Amended Registration Statement (Form S-1/A) · Filed January 27, 2026

Polaryx Therapeutics IncS-1/A exhibit

ea025123908ex-fee_polaryx.htm
Filing Fee Exhibit

Ex-Filing Fees

CALCULATION OF FILING FEE TABLES

S-1

Polaryx Therapeutics, Inc.

Table 1: Newly Registered and Carry Forward Securities

                                           
Line Item Type   Security Type   Security Class Title   Notes   Fee Calculation
Rule
  Amount Registered   Proposed Maximum Offering
Price Per Unit
  Maximum Aggregate Offering Price   Fee Rate   Amount of Registration Fee
                                           
Newly Registered Securities
Fees to be Paid   Equity   Common stock, par value $0.0001   (1)   457(a)   47,343,297   $ 10.20   $ 482,901,629.40   0.0001381   $ 66,688.72
Fees Previously Paid   Equity   Common stock, par value $0.0001       457(o)   0   $ 0.00   $ 482,600,000.00   0.0001381   $ 66,647.06
                                           
Total Offering Amounts:   $ 482,901,629.40         66,688.72
Total Fees Previously Paid:               66,647.06
Total Fee Offsets:               0.00
Net Fee Due:             $ 41.66

__________________________________________
Offering Note(s)

(1) Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), the Registrant is also registering such additional indeterminate number of ordinary shares as may become issuable as a result of share splits or share dividends.

Estimated solely for purposes of calculating the registration fee in accordance with Rule 457(d) under the Securities Act based on a market value per share reference price of $10.20.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer